Expression of GPX1 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

GPX1 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 595.42

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

843.2

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	3095.1
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	2041.4
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	1952.7
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	1910.7
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	1809.0
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	1668.1
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	1652.6
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	1591.6
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	1545.2
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	1512.4
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	1405.2
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	1383.6
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	1367.5
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	1334.6
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	1319.2
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	1280.8
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	1264.7
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	1251.0
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	1225.7
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	1222.2
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	1206.5
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	1196.0
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	1179.1
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	1156.6
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	1127.3
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	1111.7
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	1097.8
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	1095.8
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	1086.0
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	1055.8
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	1032.9
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	1028.3
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	1025.4
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	1004.5
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	986.1
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	982.0
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	976.3
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	975.2
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	966.6
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	965.4
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	964.2
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	934.2
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	926.1
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	909.5
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	909.4
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	902.5
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	893.9
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	873.5
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	870.3
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	869.2
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	868.7
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	867.8
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	865.4
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	863.0
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	858.5
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	850.7
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	834.9
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	832.3
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	821.7
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	802.4
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	800.9
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	796.6
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	796.4
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	786.6
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	773.8
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	771.7
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	766.9
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	762.4
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	762.1
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	756.1
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	753.7
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	741.6
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	737.1
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	733.7
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	725.9
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	724.6
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	721.6
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	713.9
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	709.6
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	706.8
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	705.2
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	704.7
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	701.6
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	700.3
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	697.1
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	695.1
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	693.1
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	690.3
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	686.7
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	675.4
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	661.4
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	654.5
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	653.0
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	650.3
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	644.4
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	642.0
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	637.5
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	631.9
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	621.6
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	621.5
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	620.1
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	610.7
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	603.4
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	598.0
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	592.9
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	591.4
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	588.8
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	588.1
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	586.6
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	582.9
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	582.4
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	574.9
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	564.4
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	561.0
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	556.6
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	549.1
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	548.9
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	534.9
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	529.0
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	506.4
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	504.6
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	503.8
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	488.5
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	475.9
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	473.5
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	465.2
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	453.5
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	435.3
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	426.6
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	410.1
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	409.3
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	388.3
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	379.1
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	363.9
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	358.4
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	341.1
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	330.0
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	327.7
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	308.6
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	289.1
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	273.9
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

GPX1 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 278.2

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

224.4

Number of samples

Samples

Sample	Description	pTPM
AK068	N, NA, stage:NA, alive, 360 days	747.8
AK185	N, NA, stage:NA, alive, 330 days	503.8
AK188	N, NA, stage:NA, alive, 420 days	489.6
AK098	N, NA, stage:NA, dead, 660 days	473.0
AK153	N, NA, stage:NA, dead, 240 days	446.9
AK139	N, NA, stage:NA, dead, 270 days	387.3
AK236	N, NA, stage:NA, dead, 360 days	359.4
AK053	N, NA, stage:NA, dead, 300 days	354.0
AK213	N, NA, stage:NA, alive, 2010 days	337.7
AK178	N, NA, stage:NA, dead, 240 days	335.7
AK074	N, NA, stage:NA, alive, 300 days	331.2
AK072	N, NA, stage:NA, dead, 150 days	328.8
AK055	N, NA, stage:NA, dead, 240 days	322.7
AK167	N, NA, stage:NA, dead, 180 days	315.7
AK030	N, NA, stage:NA, dead, 120 days	308.0
AK005	N, NA, stage:NA, dead, 240 days	300.1
AK183	N, NA, stage:NA, alive, 360 days	284.1
AK049	N, NA, stage:NA, dead, 180 days	282.1
AK195	N, NA, stage:NA, dead, 390 days	282.1
AK071	N, NA, stage:NA, dead, 540 days	274.3
AK199	N, NA, stage:NA, alive, 1860 days	251.0
AK051	N, NA, stage:NA, dead, 360 days	246.9
AK165	N, NA, stage:NA, alive, 360 days	242.9
AK091	N, NA, stage:NA, dead, 210 days	240.4
AK088	N, NA, stage:NA, dead, 360 days	233.4
AK003	N, NA, stage:NA, dead, 600 days	202.7
AK134	N, NA, stage:NA, dead, 360 days	202.3
AK076	N, NA, stage:NA, alive, 660 days	202.0
AK149	N, NA, stage:NA, dead, 420 days	192.9
AK124	N, NA, stage:NA, alive, 1920 days	191.3
AK227	N, NA, stage:NA, alive, 300 days	189.2
AK066	N, NA, stage:NA, alive, 960 days	182.5
AK133	N, NA, stage:NA, dead, 360 days	169.7
AK216	N, NA, stage:NA, dead, 360 days	167.8
AK218	N, NA, stage:NA, dead, 180 days	163.6
AK231	N, NA, stage:NA, dead, 240 days	154.1
AK079	N, NA, stage:NA, dead, 210 days	153.0
AK100	N, NA, stage:NA, alive, 960 days	150.8
AK158	N, NA, stage:NA, dead, 360 days	145.9
AK142	N, NA, stage:NA, alive, 90 days	127.0
AK089	N, NA, stage:NA, dead, 330 days	122.5
AK099	N, NA, stage:NA, dead, 420 days	119.3
AK085	N, NA, stage:NA, alive, 660 days	118.0
AK123	N, NA, stage:NA, dead, 180 days	113.5
AK035	N, NA, stage:NA, dead, 210 days	111.7
AK006	N, NA, stage:NA, dead, 360 days	108.8
AK015	N, NA, stage:NA, alive, 720 days	106.0
AK081	N, NA, stage:NA, dead, 180 days	104.9
AK173	N, NA, stage:NA, dead, 180 days	102.6
AK002	N, NA, stage:NA, dead, 570 days	100.8
AK043	N, NA, stage:NA, alive, 660 days	97.8
AK226	N, NA, stage:NA, dead, 360 days	94.4
AK103	N, NA, stage:NA, alive, 1320 days	93.1
AK117	N, NA, stage:NA, dead, 210 days	91.9
AK156	N, NA, stage:NA, dead, 330 days	81.4
AK041	N, NA, stage:NA, alive, 810 days	72.7
AK205	N, NA, stage:NA, dead, 120 days	52.5
AK102	N, NA, stage:NA, alive, 1740 days	49.8
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0218330004	Tumor	1.2
CPT0162020003	Tumor	0.9
CPT0093450003	Tumor	0.8
CPT0089150003	Tumor	0.8
CPT0125510003	Tumor	0.8
CPT0225760003	Tumor	0.7
CPT0104220003	Tumor	0.7
CPT0218690004	Tumor	0.7
CPT0125570003	Tumor	0.7
CPT0167970003	Tumor	0.6
CPT0168480003	Tumor	0.6
CPT0190360004	Tumor	0.5
CPT0221180003	Tumor	0.5
CPT0228220003	Tumor	0.5
CPT0064650003	Tumor	0.5
CPT0217060003	Tumor	0.4
CPT0186100003	Tumor	0.4
CPT0093550003	Tumor	0.4
CPT0206560003	Tumor	0.4
CPT0205890003	Tumor	0.3
CPT0087730003	Tumor	0.3
CPT0196850003	Tumor	0.3
CPT0127420003	Tumor	0.3
CPT0162100003	Tumor	0.3
CPT0199770003	Tumor	0.3
CPT0216920008	Tumor	0.3
CPT0209440003	Tumor	0.3
CPT0125220003	Tumor	0.3
CPT0206670004	Tumor	0.3
CPT0079790003	Tumor	0.3
CPT0206450003	Tumor	0.3
CPT0206330003	Tumor	0.3
CPT0127480003	Tumor	0.3
CPT0167640003	Tumor	0.2
CPT0093360003	Tumor	0.2
CPT0205450004	Tumor	0.2
CPT0217000004	Tumor	0.2
CPT0087950003	Tumor	0.2
CPT0167750004	Tumor	0.2
CPT0189650004	Tumor	0.2
CPT0206110003	Tumor	0.2
CPT0219080004	Tumor	0.2
CPT0224330003	Tumor	0.2
CPT0205570003	Tumor	0.2
CPT0206000004	Tumor	0.1
CPT0189460003	Tumor	0.1
CPT0204350003	Normal	0.1
CPT0189750004	Tumor	0.1
CPT0093590003	Tumor	0.1
CPT0206880003	Tumor	0.1
CPT0218960004	Tumor	0.0
CPT0168830003	Tumor	0.0
CPT0224540004	Tumor	0.0
CPT0087570003	Tumor	0.0
CPT0071100003	Tumor	0.0
CPT0182500003	Tumor	0.0
CPT0167530003	Tumor	0.0
CPT0168380003	Tumor	0.0
CPT0206230003	Tumor	0.0
CPT0225730003	Tumor	0.0
CPT0204410003	Normal	-0.1
CPT0204420003	Normal	-0.1
CPT0204370003	Normal	-0.1
CPT0168080003	Tumor	-0.1
CPT0204380003	Normal	-0.1
CPT0217880003	Tumor	-0.1
CPT0204390003	Normal	-0.1
CPT0087680003	Tumor	-0.1
CPT0217100003	Tumor	-0.1
CPT0204360003	Normal	-0.1
CPT0204340003	Normal	-0.2
CPT0168720003	Tumor	-0.2
CPT0093510003	Tumor	-0.2
CPT0175060003	Tumor	-0.2
CPT0092440003	Tumor	-0.2
CPT0189250003	Tumor	-0.2
CPT0207030003	Tumor	-0.2
CPT0190240004	Tumor	-0.2
CPT0217710008	Tumor	-0.2
CPT0217430008	Tumor	-0.2
CPT0162140003	Tumor	-0.2
CPT0208980003	Tumor	-0.2
CPT0218890004	Tumor	-0.2
CPT0078580003	Tumor	-0.2
CPT0217190003	Tumor	-0.2
CPT0182580003	Tumor	-0.2
CPT0205670004	Tumor	-0.2
CPT0218670003	Tumor	-0.3
CPT0002410011	Tumor	-0.3
CPT0204400003	Normal	-0.3
CPT0189850004	Tumor	-0.3
CPT0123530003	Tumor	-0.3
CPT0205780003	Tumor	-0.3
CPT0206780003	Tumor	-0.3
CPT0161730003	Tumor	-0.3
CPT0167860004	Tumor	-0.3
CPT0218830004	Tumor	-0.3
CPT0224600003	Tumor	-0.3
CPT0064890003	Tumor	-0.3
CPT0201710003	Tumor	-0.4
CPT0168270003	Tumor	-0.4
CPT0204330003	Normal	-0.4
CPT0182550003	Tumor	-0.4
CPT0189570004	Tumor	-0.4
CPT0207090003	Tumor	-0.4
CPT0171580008	Tumor	-0.5
CPT0168590003	Tumor	-0.5
CPT0224390004	Tumor	-0.5
CPT0104330003	Tumor	-0.5
CPT0218770003	Tumor	-0.7
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA044758	Antibody CAB011582
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, High grade
Glioma, malignant, Low grade